MindWalk Holdings (HYFT) Return on Assets (2021 - 2026)
MindWalk Holdings (HYFT) posted quarterly Return on Assets of 0.51% for Q2 2026, up 46.0% year-over-year from 0.35% in Q2 2025, and up 9.9% quarter-over-quarter from 0.46% in Q1 2026.
MindWalk Holdings (HYFT) Return on Assets (2021 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Return on Assets for 6 consecutive years, with 0.51% the latest figure, recorded in Q2 2026.
- In Q2 2026, Return on Assets rose 46.0% year-over-year to 0.51%; the TTM figure through Apr 2026 stood at 0.51% (up 46.0% YoY), while the FY2026 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Assets advanced to 0.51% in Q2 2026 per HYFT's latest filing, from 0.46% in the prior quarter.
- Across five years, Return on Assets topped out at 0.86% in Q2 2024 and bottomed at 0.0% in Q2 2023.
- Historically, Return on Assets has averaged 0.28% across 5 years, with a median of 0.16% in 2025.
- Annual changes were most pronounced in 2024 — Return on Assets surged 86 bps — and 2025, when it plunged 81 bps.
- MindWalk Holdings' Return on Assets stood at 0.0% in 2022, then surged by 42763 bps to 0.78% in 2023, then tumbled by 96 bps to 0.03% in 2024, then jumped by 1036 bps to 0.34% in 2025, then surged by 51 bps to 0.51% in 2026.
- Business Quant data shows HYFT's Return on Assets at 0.51% in Q2 2026, 0.46% in Q1 2026, and 0.34% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.01% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 0.51% |
| Jan 31, 2026 | 0.46% |
| Oct 31, 2025 | 0.34% |
| Jul 31, 2025 | 0.27% |
| Apr 30, 2025 | 0.05% |
| Jan 31, 2025 | 0.03% |
| Oct 31, 2024 | 0.03% |
| Jul 31, 2024 | 0.33% |
| Apr 30, 2024 | 0.86% |
| Jan 31, 2024 | 0.77% |
| Oct 31, 2023 | 0.78% |
| Jul 31, 2023 | 0.54% |
| Apr 30, 2023 | 0.00% |
| Jan 31, 2023 | 0.00% |
| Oct 31, 2022 | 0.00% |
| Jul 31, 2022 | 0.00% |
| Apr 30, 2022 | 0.00% |
| Jan 31, 2022 | 0.00% |
| Oct 31, 2021 | 0.00% |
| Jul 31, 2021 | 0.00% |